This study highlights why engaging with a pharmacist during clinic visits facilitates appropriate immunization and supports adult patients with cystic fibrosis (PwCF).
This study explores how a pharmacist-led mavacamten clinical management program ensures proactive management and identification of clinical and safety issues for patients on this complex therapy, as demonstrated by clinical…
Across nearly 80 health system partners, Shields maintained high-quality care while experiencing annual growth in patient volume across diverse disease states STOUGHTON, Mass. (March 3, 2026) – Shields Health Solutions…
The partnership, and investment from Shields, aims to enhance workflows for high-touch medications with innovative pharmacy operations technology, improving patient experience and reducing administrative burden STOUGHTON, Mass. (Jan. 13, 2026)…
The partnership will support patients through personalized care, medications, and coordinationShields Health Solutions (Shields), the premier specialty pharmacy accelerator in the country, has partnered with Lakeland Regional Health, one of…
Accreditation positions health system specialty pharmacies to expand access to high-value medications and supports integrated caremodels shown to reduce healthcare costs.
This poster evaluates the impact of an ambulatory clinical pharmacist (ACP) program on third party pharmacy coverage determinationoutcomes for specialty oncology medications prescribed from these clinics.
This poster evaluate the challenges, time commitments, and resource allocation associated withachieving and maintaining SP accreditation among health-system specialty pharmacies.
This poster evaluates existing oral oncology medication waste events among patients filling at a health system specialty pharmacy (HSSP).
This poster explores treatment utilization patterns and time to discontinuation (TTD) in patients receiving ALK TKIs for ALK+ mNSCLC.